Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-29
Closed -$2.85K 2723
2025
Q2
$2.85K Buy
29
+14
+93% +$1.32K ﹤0.01% 1023
2025
Q1
$1.39K Buy
+15
New +$1.38K ﹤0.01% 1145

Other funds holding AMED

True Wealth Design's AMED Position: Q3 2025 in Review

True Wealth Design sold out of Amedisys (AMED) in Q3 2025, closing a stake of 29 shares — an estimated $2.85K sold.

True Wealth Design first reported a position in AMED in Q1 2025 and held it in 2 quarters. The position peaked at $2.85K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • True Wealth Design reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • True Wealth Design sold 29 Amedisys shares in Q3 2025, an estimated $2.85K.
  • True Wealth Design first reported a position in Amedisys in Q1 2025 and held it in 2 quarters.
  • True Wealth Design's Amedisys position peaked at $2.85K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.